Vriesendorp P A, Wilschut J M, Diletti R, Daemen J, Kardys I, Zijlstra F, Van Mieghem N M, Bennett J, Esposito G, Sabate M, den Dekker W K
Department of Cardiology, Thoraxcenter, Erasmus University Medical Centre, Rotterdam, The Netherlands.
The Heart Centre, The Alfred Hospital, Melbourne, Australia.
Neth Heart J. 2022 Oct;30(10):449-456. doi: 10.1007/s12471-022-01687-7. Epub 2022 May 10.
Although there is robust evidence that revascularisation of non-culprit vessels should be pursued in patients presenting with an acute coronary syndrome (ACS) and multivessel coronary artery disease (MVD), the optimal timing of complete revascularisation remains disputed. In this systematic review and meta-analysis our results suggest that outcomes are comparable for immediate and staged complete revascularisation in patients with ACS and MVD. However, evidence from randomised controlled trials remains scarce and cautious interpretation of these results is recommended. More non-biased evidence is necessary to aid future decision making on the optimal timing of complete revascularisation.
尽管有充分证据表明,对于患有急性冠状动脉综合征(ACS)和多支冠状动脉疾病(MVD)的患者,应进行非罪犯血管的血运重建,但完全血运重建的最佳时机仍存在争议。在这项系统评价和荟萃分析中,我们的结果表明,ACS和MVD患者立即进行完全血运重建和分期进行完全血运重建的结果相当。然而,随机对照试验的证据仍然很少,建议对这些结果进行谨慎解读。需要更多无偏倚的证据来帮助未来在完全血运重建最佳时机方面做出决策。